Bill
Bill > S2465
US S2465
US S2465Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
summary
Introduced
02/28/2018
02/28/2018
In Committee
07/25/2018
07/25/2018
Crossed Over
10/16/2018
10/16/2018
Passed
12/13/2018
12/13/2018
Dead
Signed/Enacted/Adopted
12/18/2018
12/18/2018
Introduced Session
115th Congress
Bill Summary
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
AI Summary
This bill amends the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment. Specifically, it authorizes the Secretary to award grants to collect and maintain data on heritable blood disorders like sickle cell disease, conduct public health activities to improve health outcomes and access to quality care, and support state health departments and regional laboratories in testing and identifying these conditions. The bill also reauthorizes and modifies the existing sickle cell disease prevention and treatment demonstration program, extending it until 2023. Additionally, the bill expresses the Sense of the Senate that further research should be undertaken to expand the understanding of the causes of, and find cures for, heritable blood disorders, including sickle cell disease.
Committee Categories
Health and Social Services
Sponsors (7)
Tim Scott (R)*,
Cory Booker (D),
Sherrod Brown (D),
Bill Cassidy (R),
Doug Jones (D),
Debbie Stabenow (D),
Elizabeth Warren (D),
Last Action
Became Public Law No: 115-327. (on 12/18/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...